Growth Metrics

Ardelyx (ARDX) EBT (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Ardelyx 1.48 Bn 1.25 Bn 89.66 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -9,299.25%
Dec 31, 2025 53.86%
Sep 30, 2025 95.46%
Jun 30, 2025 52.64%
Mar 31, 2025 -960.79%
Dec 31, 2024 710.97%
Sep 30, 2024 95.33%
Jun 30, 2024 37.92%
Mar 31, 2024 7.28%
Dec 31, 2023 -516.88%
Sep 30, 2023 139.89%
Jun 30, 2023 36.02%
Mar 31, 2023 -350.20%
Dec 31, 2022 146.72%
Sep 30, 2022 15.00%
Jun 30, 2022 4.05%
Mar 31, 2022 22.53%
Dec 31, 2021 16.87%
Sep 30, 2021 3.54%
Jun 30, 2021 -36.29%
Mar 31, 2021 -14.82%
Dec 31, 2020 -59.45%
Sep 30, 2020 27.44%
Jun 30, 2020 -11.55%
Mar 31, 2020 -13.05%
Dec 31, 2019 14.84%
Sep 30, 2019 8.75%
Jun 30, 2019 2.58%
Mar 31, 2019 6.18%
Dec 31, 2018 -15.49%
Sep 30, 2018 -8.24%
Jun 30, 2018 -31.00%
Mar 31, 2018 -250.67%
Dec 31, 2017 154.49%
Sep 30, 2017 19.43%
Jun 30, 2017 8.17%
Mar 31, 2017 10.44%
Dec 31, 2016 -7.73%
Sep 30, 2016 -1.46%
Jun 30, 2016 -21.93%
Mar 31, 2016 -38.05%
Dec 31, 2015 6.37%
Sep 30, 2015 -301.58%
Jun 30, 2015 357.20%
Mar 31, 2015 10.30%
Dec 31, 2014 -5,375.68%
Sep 30, 2014 -98.03%
Jun 30, 2014 222.21%
Mar 31, 2014 27.47%
Dec 31, 2013 -370.97%
Sep 30, 2013 -5.15%